Latest filing published 08 Mar 2021 for Alaunos Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Jill Buck: trading record in brief
Jill Buck discloses dealings in Alaunos Therapeutics, Inc. to SEC (Form 4). Between 2 January 2020 and 4 March 2021, the trades on record add up to 4 filings.
Every open-market trade on record is a sale: 2 sales worth €184k. Outside the open market, there are 2 share grants. 2021 to date brings no purchases and 1 sale.
The newest entry dates from 8 March 2021: a share grant, in Alaunos Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jill Buck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 31,500 shares0Common StockSEC:0001209191-21-018632:0
- 27,894 shares@ US$3.1238.5% of flowCommon StockSEC:0001209191-21-003245:0
- 53,700 shares0Common StockSEC:0001209191-20-005778:0
- 27,923 shares@ US$4.55100.0% of flowCommon StockSEC:0001209191-20-001167:0
4 of 4 declarations